NumerixS Investment Technologies’s Alder Biopharmaceuticals ALDR Stock Holding History

NumerixS Investment Technologies’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,100	Closed	-$13K	–	1356
2019 Q2	$13K	Buy	+1,100	New	+$13.3K	﹤0.01%	956
2018 Q3	–	Sell	-100	Closed	-$2K	–	1447
2018 Q2	$2K	Sell	100 -17,300	-99%	-$263K	﹤0.01%	1083
2018 Q1	$211K	Buy	17,400 +300	+2%	+$4.34K	0.05%	383
2017 Q4	$196K	Sell	17,100 -3,500	-17%	-$39.1K	0.04%	467
2017 Q3	$252K	Sell	20,600 -30,700	-60%	-$320K	0.06%	448
2017 Q2	$587K	Buy	51,300 +32,000	+166%	+$592K	0.09%	289
2017 Q1	$401K	Buy	19,300 +18,000	+1,385%	+$398K	0.05%	501
2016 Q4	$27K	Sell	1,300 -7,100	-85%	-$185K	﹤0.01%	1019
2016 Q3	$275K	Buy	+8,400	New	+$256K	0.04%	580

Other funds holding ALDR

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return